Inventor · Gurnee, IL, US

Hong Ding

34Patents
18h-index
55Co-inventors
84Inventor score

Filing activity: Sep 20, 2001 → Oct 7, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7390799B2 Apoptosis promoters Chemistry; Metallurgy 197 Active
US7767684B2 Apoptosis promoters Chemistry; Metallurgy 87 Active
US8563735B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 70 Active
US7642260B2 Apoptosis promoters Chemistry; Metallurgy 60 Active
US8546399B2 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 57 Active
US8586754B2 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 55 Active
US6720338B2 N-acylsulfonamide apoptosis promoters Chemistry; Metallurgy 54 Expired
US7973161B2 Apoptosis promoters Chemistry; Metallurgy 50 Active
US8426422B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 47 Active
US7504512B2 N-acylsulfonamide apoptosis promoters Chemistry; Metallurgy 43 Expired
US8173811B2 Apoptosis promoters Chemistry; Metallurgy 42 Active
US8084607B2 Apoptosis promoters Chemistry; Metallurgy 37 Active
US8614318B2 Apoptosis promoters Chemistry; Metallurgy 35 Active
US7709467B2 Apoptosis promoters Chemistry; Metallurgy 35 Active
US8354404B2 Apoptosis promoters Chemistry; Metallurgy 33 Active
US8343967B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 32 Active
US7754886B2 N-acylsulfonamide apoptosis promoters Chemistry; Metallurgy 29 Active
US8952157B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 19 Active
US8686136B2 Apoptosis promoters Chemistry; Metallurgy 17 Active
US9174982B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 15 Active
US9315488B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 11 Active
US9303025B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 9 Active
US9072748B2 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 9 Active
US9045444B2 Apoptosis promoters Chemistry; Metallurgy 9 Active
US7906505B2 Apoptosis promoters Chemistry; Metallurgy 8 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.